uniQure (QURE) EBITDA (2016 - 2026)
uniQure (QURE) recorded quarterly EBITDA of -$55.2 million in Q1 2026, down 50.97% quarter-over-quarter from -$36.6 million in Q4 2025, and down 23.65% on a YoY basis from -$72.3 million in Q1 2025.
uniQure (QURE) EBITDA (2016 - 2026) Analysis & Trends
uniQure's EBITDA history runs 11 years deep, the most recent figure standing at -$55.2 million for Q1 2026.
- In Q1 2026, EBITDA fell 23.65% year-over-year to -$55.2 million; the TTM figure through Mar 2026 stood at -$214.9 million (changed 0.18% YoY), while the FY2025 annual figure was -$204.4 million, up 14.41% from the prior year.
- EBITDA was -$55.2 million for Q1 2026 at uniQure, down from -$36.6 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $41.5 million in Q4 2022 to a low of -$95.7 million in Q3 2023.
- Historically, EBITDA has averaged -$56.4 million across 5 years, with a median of -$67.4 million in 2022.
- The sharpest annual moves came in 2022 and 2023: EBITDA soared 1601.48% in 2022, then plunged 264.28% in 2023.
- A 5-year view of EBITDA shows it stood at $41.5 million in 2022, then slumped by 264.28% to -$68.2 million in 2023, then decreased by 1.7% to -$69.4 million in 2024, then soared by 47.29% to -$36.6 million in 2025, then slumped by 50.97% to -$55.2 million in 2026.
- The last three EBITDA figures came in at -$55.2 million (Q1 2026), -$36.6 million (Q4 2025), and -$80.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -55.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.20 Mn |
| Dec 31, 2025 | -36.56 Mn |
| Sep 30, 2025 | -80.37 Mn |
| Jun 30, 2025 | -42.82 Mn |
| Mar 31, 2025 | -44.64 Mn |
| Dec 31, 2024 | -69.36 Mn |
| Sep 30, 2024 | -44.76 Mn |
| Jun 30, 2024 | -56.58 Mn |
| Mar 31, 2024 | -68.11 Mn |
| Dec 31, 2023 | -68.20 Mn |
| Sep 30, 2023 | -95.69 Mn |
| Jun 30, 2023 | -68.42 Mn |
| Mar 31, 2023 | -71.43 Mn |
| Dec 31, 2022 | 41.52 Mn |
| Sep 30, 2022 | -73.23 Mn |
| Jun 30, 2022 | -67.39 Mn |
| Mar 31, 2022 | -57.13 Mn |
| Dec 31, 2021 | -2.77 Mn |
| Sep 30, 2021 | -49.82 Mn |
| Jun 30, 2021 | 392.53 Mn |